Influenza virus vaccine 2024-2025 (trivalent - Georgia/Sydney/Singapore) 0.5 mL Prefilled Syringe
RxNorm 2688123
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2688123 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: influenza virus vaccine 2024-2025 (trivalent - Georgia/Sydney/Singapore) 0.5 mL Prefilled Syringe.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
0.5 mL influenza A virus A/Georgia/12/2022 (H1N1) antigen 0.03 mg/ML / influenza A virus A/Sydney/1304/2022 (H3N2) antigen 0.03 mg/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 mg/ML Prefilled Syringe
(Atom ID: 12899794)
PSNPrescribable
Prescribable Name (PSN):
Influenza virus vaccine 2024-2025 (trivalent - Georgia/Sydney/Singapore) 0.5 mL Prefilled Syringe
(Atom ID: 12899821)
SYPrescribable